Showing results (81-90 of 133) with videos related to
Sort By:
Pageof 14
Journal for Immunotherapy of Cancer|June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapyRyan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 22, 2021
Development, Practice Patterns, and Early Clinical Outcomes of a Multidisciplinary Liver Cancer ClinicAngela Y Jia, Aleksandra Popovic, Aditya A Mohan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 BlockadeJulie E Stein, Evan J Lipson, Tricia R Cottrell, et al.Nature Reviews. Clinical Oncology|June 10, 2026
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statementJosep M Llovet, Ezequiel Mauro, Lorenza Rimassa, et al.Cancer Immunology Research|March 24, 2019
Multiple Immune-Suppressive Mechanisms in Fibrolamellar CarcinomaAmy K Kim, Faiz Gani, Andrew J Layman, et al.Healthcare (Basel, Switzerland)|September 28, 2023
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center AnalysisAmol Gupta, Jane Zorzi, Won Jin Ho, et al.American Journal of Hematology|February 22, 2019
Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitorsRebecca Karp Leaf, Christopher Ferreri, Deepa Rangachari, et al.Journal of Oncology Practice|August 7, 2019
Immune-Related Adverse Events Requiring Hospitalization: Spectrum of Toxicity, Treatment, and OutcomesAanika Balaji, Jiajia Zhang, Beatriz Wills, et al.Cancer Research Communications|October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsTheron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.Hepatology (Baltimore, Md.)|December 3, 2024
Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinomaDaniel J Zabransky, Emma Kartalia, Jae W Lee, et al.Pageof 14